|
Volumn 39, Issue 3, 2007, Pages 747-749
|
Tacrolimus (Pan Graf) in Live Related Renal Transplantation: An Initial Experience of 101 Recipients in India
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
BASILIXIMAB;
CORTICOSTEROID;
DACLIZUMAB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PAN GRAF;
STEROID;
TACROLIMUS;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG SAFETY;
EXPERIENCE;
FEMALE;
FOLLOW UP;
GRAFT DYSFUNCTION;
GRAFT RECIPIENT;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEPATITIS C VIRUS;
HUMAN;
INDIA;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RELATIVE;
SCHOOL CHILD;
SURVIVAL RATE;
ADOLESCENT;
ADULT;
AZATHIOPRINE;
CHILD;
DRUG THERAPY, COMBINATION;
FAMILY;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TACROLIMUS;
|
EID: 34247165687
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2007.01.056 Document Type: Article |
Times cited : (5)
|
References (7)
|